Outset Medical Inc. (OM)
NASDAQ: OMHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
OM stock chart
Technical analysisKey statistics
All statistics- Market cap
- $53.03M
- EPS (TTM)
- -$3.78
- Dividend yield
- None
- 52-week range
- 2.77 – 6.49
- Day range
- 2.77 – 3.02
- Volume / Avg
- 81.32K / 140.40K
- Beta
- —
- Shares outstanding
- 18.87M
52-week range
OM stock today
On Nov 20, OM ended the session at $2.81, shedding $0.10 (3.44%), versus the S&P 500's 3.70% decline. At this level, OM sits near the bottom of its 52-week range of $2.77 to $6.49: 56.7% below the high, set on Jan 12, 2026 and 1.4% above the low. OM is down 24.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 34.5%.
Outset Medical has posted a net loss over the last twelve months (EPS of -$3.78), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Outset Medical
Company profileOutset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform.
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CEO
- Ms. Leslie L. Trigg
- Headquarters
- San Jose, CA
- Employees
- 310
- IPO year
- 2020
- Website
- outsetmedical.com
Financial highlights
Full financialsIn fiscal 2025, Outset Medical generated $119.5 million in revenue, up 5.1% from fiscal 2024. Outset Medical reported a net loss of $81.7 million, compared with a loss of $128.0 million a year earlier. Gross margin was 39.1% (up from 33.9%) and operating margin -55.8%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $119.48M | $113.69M | $130.38M | $115.38M | $102.60M |
| Growth | +5.09% | -12.80% | +13.00% | +12.45% | +105.47% |
| Net income | $-81.65M | $-127.98M | $-172.80M | $-162.96M | $-131.94M |
| EPS (diluted) | $-5.37 | $-36.96 | $-52.28 | $-3.38 | $-2.89 |
Analyst forecast
ForecastConsensus (3 analysts)
buy
Avg. price target
$7.67+172.95%
- Strong buy 0
- Buy 2
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 4, 2026
- EPS actual vs est.
- $-0.78 vs $-0.84
- Surprise
- +7.14%
OM news
All OM news- Osisko Metals Announces Closing of C$250 Million Special Warrant Financing by Osisko Critical Minerals CorporationGlobeNewswire
- Outset Medical Reports Third Quarter 2026 ResultsGlobeNewswire
- Osisko Metals Closes C$25 Million Flow-Through Share FinancingGlobeNewswire
- Osisko Intersects 314 Metres Averaging 0.44% Cu at GaspéGlobeNewswire
- Osisko recoupe 314 mètres à une teneur moyenne de 0,44 % cuivre à Mines GaspéGlobeNewswire
- Outset Medical to Participate in the 2026 Stifel Healthcare ConferenceGlobeNewswire
- Outset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026GlobeNewswire
- Here's Why You Should Retain DaVita Stock in Your Portfolio for NowNasdaqDVA, MMSI, GMED, OM
Outset Medical peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| HYPRHyperfine Inc. Class A | 0.5465 | +4.27% | $57.96M | vs OM |
| NRXSNeuraxis Inc. | 4.22 | -6.22% | $59.90M | vs OM |
| POCIPrecision Optics Corporation Inc. | 4.12 | +1.41% | $45.30M | vs OM |
| ECORelectroCore Inc. | 4.42 | -8.87% | $40.78M | vs OM |
| QTIQT Imaging Holdings Inc. | 1.92 | +2.67% | $28.21M | vs OM |
| HSDTSolana Company Class A | 1.49 | -10.24% | $93.70M | vs OM |
| ITOCiTonic Holdings Ltd Class A | 1.59 | +6.00% | $11.63M | vs OM |
| STXSStereotaxis Inc. | 0.9422 | -6.71% | $95.03M | vs OM |
Indexes, lists and sector
Outset Medical stock FAQ
What is Outset Medical's stock price today?
OM last traded at $2.81 as of Nov 20, 4:00 PM EST, down 3.44% on the day. Prices are delayed at least 15 minutes.
Does Outset Medical pay a dividend?
No. Outset Medical does not currently pay a regular cash dividend.
Who is Outset Medical's CEO?
Ms. Leslie L. Trigg is the chief executive officer of Outset Medical Inc., which has about 310 employees.
Has OM ever split its stock?
Yes. The most recent OM stock split was a 1-for-15 split on Mar 20, 2025.
What is the OM 52-week high?
The 52-week high for OM is $6.49 and the 52-week low is $2.77. The stock is currently 56.7% below its high.